Results 1 to 10 of about 136,260 (186)
Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT. [PDF]
PLoS ONE, 2018 To investigate the value of spectral CT in the differential diagnosis of benign from malignant pleural effusion.14 patients with benign pleural effusion and 15 patients with malignant pleural effusion underwent non-contrast spectral CT imaging.
Xirong Zhang +7 more
doaj +2 more sources
The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion. [PDF]
PLoS ONE, 2016 The aim of our study was to evaluate the role of 18F-FDG PET/CT integrated imaging in differentiating malignant from benign pleural effusion.A total of 176 patients with pleural effusion who underwent 18F-FDG PET/CT examination to differentiate ...
Yajuan Sun +3 more
doaj +2 more sources
The significance of Fas, tumor necrosis factor-related apoptosis-inducing ligand and fibrinolytic factors in the assessment of malignant pleural effusion [PDF]
Archives of Biological Sciences, 2022 Few studies have examined the usefulness of soluble apoptotic markers for the screening of pleural effusion. This study aimed to investigate the significance of Fas, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and fibrinolytic factors
Choi Jong Weon +2 more
doaj +1 more source
Nature Nanotechnology, 2021 Malignant pleural effusion (MPE) is indicative of terminal malignancy with a uniformly fatal prognosis. Often, two distinct compartments of tumour microenvironment, the effusion and disseminated pleural tumours, co-exist in the pleural cavity, presenting
Yang Liu +15 more
semanticscholar +1 more source
BMC Pulmonary Medicine, 2023 Aim To investigate the diagnostic value of combined detection of SHOX2 and RASSF1A gene methylation with carcinoembryonic antigen (CEA) level in diagnosing malignant pleural effusion.
Shaosen Chen +4 more
doaj +1 more source
Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
Translational Lung Cancer Research, 2021 Although cytology and pleural biopsy of pleural effusion (PE) are the gold standards for diagnosing malignant pleural effusion (MPE), these tools’ diagnostic accuracy is plagued by some limitations such as low sensitivity, considerable inter-observer ...
Man Zhang, Li Yan, G. Lippi, Zhi-De Hu
semanticscholar +1 more source
Lung Cancer, 2021 The role of PET and integrated PET-CT in the diagnostic workup of suspected malignant pleural effusions is unknown. Earlier systematic reviews (published 2014 and 2015) both included pleural pathology without effusion, and reached contradictory ...
K. Fjaellegaard +9 more
semanticscholar +1 more source
Malignant pleural effusion [PDF]
QJM, 2013 Malignant pleural effusion (MPE) refers to the presence of neoplastic cells in the pleural fluid. Approximately 40 000 people per year in the UK are affected by MPE and it is associated with significant morbidity and an overall poor prognosis. Management should be prompt and care plans should be individualized and involve a multidisciplinary team of ...
Egan, A. M. +3 more
openaire +3 more sources
Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
Thoracic Cancer, 2020 Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male.
Eiji Takeuchi +6 more
doaj +1 more source
Life, 2023 Malignant pleural effusion is associated with a poor prognosis and, while risk stratification models exist, prior studies have not evaluated pleural fluid resolution and its association with survival.
Christina R. MacRosty +5 more
doaj +1 more source